Breaking News, Promotions & Moves

Amarna Therapeutics Names New CEO

Dr. Steen Klysner brings 30 years of experience in the life sciences industry.

By: Contract Pharma

Contract Pharma Staff

Amarna Therapeutics, a privately held biotechnology company, has appointed Steen Klysner, Ph.D. as its new chief executive officer as per September 1. Founder and CEO Ben van Leent will become a member of Amarna’s Supervisory Board.   “I am very pleased to welcome Steen Klysner as our new CEO. Steen brings an extensive background as a biotech CEO to Swedish ExpreS2ion Biotech Holding AB & the Danish ExpreS2ion Biotechnologies ApS, preceded by an impressive track record in executi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters